Phreesia Life Sciences
Climate Impact & Sustainability Data (2021-12 to 2022-01)
Reporting Period: 2021-12 to 2022-01
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Not disclosed
Environmental Achievements
- Not disclosed
Social Achievements
- Not disclosed
Governance Achievements
- Not disclosed
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Limited patient awareness of available diabetes medications and their effectiveness.
- Low patient satisfaction with some commonly used diabetes medications.
- Underutilization of non-pharmacological treatments like exercise.
- Lack of mental health support for patients with Type 2 diabetes.
- Widespread unawareness of diabetes complications among patients.
Mitigation Strategies
- Raise brand awareness at the point of care.
- Provide comprehensive information about diabetes medications.
- Take a holistic approach to helping patients by offering treatments for comorbidities and providing support.
- Provide educational resources to explain increased medical risks.
- Consider and cater for the impact of Type 2 diabetes on mental health.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed